159 related articles for article (PubMed ID: 31261510)
1. Integrative cancer treatment may have a survival benefit in patients with lung cancer: A retrospective cohort study from an integrative cancer center in Korea.
Bae K; Kim E; Kong JS; Kim J; Park SJ; Jun HJ; Cho CK; Kim MK; Yoo HS
Medicine (Baltimore); 2019 Jun; 98(26):e16048. PubMed ID: 31261510
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Chemotherapy Integrated With Traditional Korean Medicine in Patients With Metastatic Pancreatic Cancer: A Single-Center Retrospective Study.
Kim EH; Yoon JH; Yoon SS; Lee JY; Yoon SW
Integr Cancer Ther; 2020; 19():1534735420983457. PubMed ID: 33349074
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of anticancer traditional Korean medicine treatment on the survival in patients with lung, breast, gastric, colorectal, hepatic, uterine, or ovarian cancer: A prospective cohort study protocol.
Bae K; Kim E; Choi JJ; Kim MK; Yoo HS
Medicine (Baltimore); 2018 Oct; 97(41):e12444. PubMed ID: 30313034
[TBL] [Abstract][Full Text] [Related]
4. Usage patterns and adverse experiences in traditional Korean medicine: results of a survey in South Korea.
Shin HK; Jeong SJ; Huang DS; Kang BK; Lee MS
BMC Complement Altern Med; 2013 Dec; 13():340. PubMed ID: 24289266
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer.
Cheon SH; Kim KS; Kim S; Jung HS; Choi WC; Eo WK
Forsch Komplementmed; 2011; 18(2):77-83. PubMed ID: 21576976
[TBL] [Abstract][Full Text] [Related]
6. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.
Segev Y; Lavie O; Stein N; Saliba W; Samuels N; Shalabna E; Raz OG; Schiff E; Ben-Arye E
Support Care Cancer; 2021 Jul; 29(7):4055-4064. PubMed ID: 33404816
[TBL] [Abstract][Full Text] [Related]
7. Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort Study.
Ha SJ; Kwag E; Kim S; Park JH; Park SJ; Yoo HS
Integr Cancer Ther; 2023; 22():15347354231154267. PubMed ID: 37615075
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in prognosis factors in patients with lung cancer: A nationwide retrospective cohort study in Korea.
Huh Y; Sohn YJ; Kim HR; Chun H; Kim HJ; Son KY
PLoS One; 2024; 19(5):e0300389. PubMed ID: 38728284
[TBL] [Abstract][Full Text] [Related]
9. Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities.
Bilfinger T; Keresztes R; Albano D; Nemesure B
Med Sci Monit; 2016 Jul; 22():2589-94. PubMed ID: 27442604
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment.
Sullivan DR; Forsberg CW; Ganzini L; Au DH; Gould MK; Provenzale D; Slatore CG
J Clin Oncol; 2016 Nov; 34(33):3984-3991. PubMed ID: 27996350
[TBL] [Abstract][Full Text] [Related]
11. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
[TBL] [Abstract][Full Text] [Related]
12. Integrative traditional Korean medicine treatment for children with idiopathic short stature: A STROBE-compliant case series.
Kim YJ; Lee SH; Jang S; Lee JY; Chang GT; Lee B
Medicine (Baltimore); 2022 Jul; 101(28):e29754. PubMed ID: 35839047
[TBL] [Abstract][Full Text] [Related]
13. Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.
Sullivan DR; Chan B; Lapidus JA; Ganzini L; Hansen L; Carney PA; Fromme EK; Marino M; Golden SE; Vranas KC; Slatore CG
JAMA Oncol; 2019 Dec; 5(12):1702-1709. PubMed ID: 31536133
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a 'Watch and Wait' Approach for Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell Lung Cancer from a Diverse Community Population.
Noonan K; Tong KM; Laskin J; Zheng YY; Melosky B; Sun S; Murray N; Ho C
Clin Oncol (R Coll Radiol); 2015 Sep; 27(9):505-13. PubMed ID: 26095646
[TBL] [Abstract][Full Text] [Related]
15. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
[TBL] [Abstract][Full Text] [Related]
17. Impact of Targeted Therapy on the Survival of Patients With Advanced-Stage Non-small Cell Lung Cancer in Oncosalud - AUNA.
Aguilar A; Mas L; Enríquez D; Vallejos C; Gutarra R; Flores CJ
Cancer Control; 2022; 29():10732748211068637. PubMed ID: 35030060
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland.
Augustin M; Bock PR; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2005; 55(1):38-49. PubMed ID: 15727163
[TBL] [Abstract][Full Text] [Related]
19. Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea.
Park HY; Hwang J; Kim DH; Jeon SM; Choi SH; Kwon JW
BMC Cancer; 2020 Sep; 20(1):846. PubMed ID: 32883237
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of standardized allergen-removed Rhus verniciflua extract as maintenance therapy after first-line chemotherapy in patients with advanced non-small cell lung cancer.
Lee J; Chae J; Lee S; Kim K; Eo W; Kim S; Choi W; Cheon SH
Am J Chin Med; 2013; 41(4):773-87. PubMed ID: 23895151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
